Showing Results for
- Academic Journals (72)
Search Results
- 72
Academic Journals
- 72
- Search Terms:
- 1From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Alan Dove At the annual meeting of the American Association for the Advancement of Science in February, researchers presented results that provide some validation of the "shotgun" genome-sequencing approach...
- 2From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Henry Miller [1]; Gregory Conko [2] In an editorial last month, this journal pointed out that the biosafety protocol recently completed in Montreal "violates a cardinal principal of regulation--namely, that...
- 3From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Julie Grisham In late February, the European Patent Office (EPO; Munich, Germany) admitted a mistake in a patent issued last December for a technology that could include cloning of humans. The English...
- 4From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Robert Schehr; Jeff Fox On March 14, US President Bill Clinton and UK Prime Minister Tony Blair released a joint statement exhorting industry to make public "raw, fundamental data on the human genome,...
- 5From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Emma Dorey In mid-February, Gemini Holdings (Cambridge, UK) announced an agreement with Lineage Biomedical (St. John's, Newfoundland) to establish a joint venture, Newfound Genomics, to look at how genes...
- 6From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Richard Gilmore [1] Lurking behind the debate on genetically modified organisms (GMOs) is the phantom fear of the ownership of staple food resources. Corporate control and US domination may, in fact, be the...
- 7From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Keely Savoie ProdiGene (College Station, TX) announced in February that its patented edible vaccine confers protection against the common transmissible gastrointestinal virus in pigs. The vaccine, produced...
- 8From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedInternet trading has put the knee-jerk reaction back in vogue. With company news moving around the globe at the speed of electrons, the rewards for those who act quickly on it can be high. For instance, investors who...
- 9From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedFeRx (San Diego, CA) has named Vicente Anido Jr. to its board of directors. Most recently, he was president and CEO of CombiChem, which was sold to DuPont Pharmaceuticals last year. Wolfgang Berthold has been...
- 10From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Asako Saegusa Japan's Science and Technology Agency (Tokyo) has released draft legislation that prohibits the use of cloning techniques for human reproductive purposes. It also bars implantation of chimeric...
- 11From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Emma Dorey At the start of March, Cambridge Antibody Technology (Cambridge, UK) announced a 10-year, $67 million agreement with genomics company Human Genome Sciences (Rockville, MD) to turn human genome...
- 12From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Julie Grisham A nonprofit institute recently established at the University of Wisconsin (Madison, WI) plans to widely distribute human embryonic stem cells to qualified researchers in academia and industry....
- 13From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Kevin D'Amour [1]; Fred H. Gage [1] The establishment of immortal, pluripotent stem cell lines has given rise to a powerful tool for in vitro research of developmental processes at both cellular and...
- 14From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedWe are poised at the beginning of a century when--according to virtually all the most well-informed commentators--our understanding of human health and disease will turn medicine on its head. That understanding takes as...
- 15From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedCombinatorial chemistry [illus. 1] Phase separator The Lollipop Phase Separator from Radley's (Essex, UK) is designed for the purification of organic and aqueous phases from a two-phase mixture. Its principle is...
- 16From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Julie Grisham Three Massachusetts biotechnology companies announced in mid-February that they are merging to form Curis, a company that aims to be a leader in the emerging field of regenerative medicine. The...
- 17From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Julie Grisham PPL Therapeutics (Edinburgh, UK), the company that, along with the Roslin Institute, cloned Dolly the sheep, announced on March 14 that it had created the first pigs cloned from adult cells....
- 18From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedAuthor(s): Natalie DeWitt Phosphate-a limiting nutrient for agriculture-is applied to soils worldwide by the millions of tons. However, in alkaline or acid soils, phosphate forms insoluble precipitates making most of...
- 19From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedWe describe the derivation of pluripotent embryonic stem (ES) cells from human blastocysts. Two diploid ES cell lines have been cultivated in vitro for extended periods while maintaining expression of markers...
- 20From: Nature Biotechnology. (Vol. 18, Issue 4) Peer-ReviewedThe completion of the Human Genome Project has made possible the comprehensive analysis of gene expression, and cDNA microarrays are now being employed for expression analysis in cancer cell lines or excised surgical...